• Je něco špatně v tomto záznamu ?

Decrease in serum calcitriol (but not free 25-hydroxyvitamin D) concentration in hip fracture healing

J. Vaculik, L. Wenchich, M. Bobelyak, K. Pavelka, JJ. Stepan

. 2021 ; 44 (9) : 1847-1855. [pub] 20210125

Jazyk angličtina Země Itálie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22012251

Grantová podpora
00023728 Ministerstvo zdravotnictví České Republiky (CZ)

OBJECTIVE: To assess the decrease in serum calcitriol concentrations after hip fracture. METHODS: Serum concentrations of calcitriol, 25(OH)D, parathyroid hormone (PTH), directly measured free 25(OH)D, and indices of bone formation were measured in elderly patients with hip fracture (HF) and patients with elective hip replacement (EHR) at admission and after 7 weeks. RESULTS: A total of 45 patients with HF and 17 patients with EHR completed this prospective study. Baseline serum calcitriol levels were ≤ 60 pmol/l in 26% of the HF patients. After 7 weeks, they significantly decreased (p < 0.001). In patients with EHR, serum calcitriol was within the reference range in all but one patient and did not change during the 7-week recovery phase. Seven weeks after HF, a significant positive relationship was observed between the change in calcitriol and serum 25(OH)D concentration (r = 0.385, p = 0.009) and free 25(OH)D (r = 0.296, p = 0.048), and a decrease in calcitriol during recovery was associated with a decrease in serum PTH (p = 0.038). Seven weeks after HF, changes in both serum PTH and serum 25(OH)D concentrations contributed to the prediction of changes in serum calcitriol (R2 = 0.190, p = 0.012). CONCLUSIONS: Unlike patients with EHR, subjects with HF had low serum 25(OH)D and low free 25(OH)D concentrations at admission, while their serum 1,25D levels were relatively elevated. Decreases in circulating calcitriol levels in the 7 weeks following hip surgery were associated with a resolution of secondary hyperparathyroidism and low availability of free 25(OH)D.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012251
003      
CZ-PrNML
005      
20220506130020.0
007      
ta
008      
220425s2021 it f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s40618-020-01489-x $2 doi
035    __
$a (PubMed)33492601
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Vaculik, J $u Orthopedic Department, Bulovka Hospital, Prague, Czech Republic $u Faculty of Medicine 1, Charles University, Prague, Czech Republic $u Faculty of Medicine 3, Charles University, Prague, Czech Republic
245    10
$a Decrease in serum calcitriol (but not free 25-hydroxyvitamin D) concentration in hip fracture healing / $c J. Vaculik, L. Wenchich, M. Bobelyak, K. Pavelka, JJ. Stepan
520    9_
$a OBJECTIVE: To assess the decrease in serum calcitriol concentrations after hip fracture. METHODS: Serum concentrations of calcitriol, 25(OH)D, parathyroid hormone (PTH), directly measured free 25(OH)D, and indices of bone formation were measured in elderly patients with hip fracture (HF) and patients with elective hip replacement (EHR) at admission and after 7 weeks. RESULTS: A total of $a OBJECTIVE To assess the decrease in serum calcitriol concentrations after hip fracture METHODS Serum concentrations of calcitriol 25 OH D parathyroid hormone PTH directly measured free 25 OH D and indices of bone formation were measured in elderly patients with hip fracture HF and patients with elective hip replacement EHR at admission and after 7 weeks RESULTS A total of 45 patients wit $a OBJECTIVE: To assess the decrease in serum calcitriol concentrations after hip fracture. METHODS: Serum concentrations of calcitriol, 25(OH)D, parathyroid hormone (PTH), directly measured free 25(OH)D, and indices of bone formation were measured in elderly patients with hip fracture (HF) and patients with elective hip replacement (EHR) at admission and after 7 weeks. RESULTS: A total of 45 patients with HF and 17 patients with EHR completed this prospective study. Baseline serum calcitriol levels were ≤ 60 pmol/l in 26% of the HF patients. After 7 weeks, they significantly decreased (p < 0.001). In patients with EHR, serum calcitriol was within the reference range in all but one patient and did not change during the 7-week recovery phase. Seven weeks after HF, a significant positive relationship was observed between the change in calcitriol and serum 25(OH)D concentration (r = 0.385, p = 0.009) and free 25(OH)D (r = 0.296, p = 0.048), and a decrease in calcitriol during recovery was associated with a decrease in serum PTH (p = 0.038). Seven weeks after HF, changes in both serum PTH and serum 25(OH)D concentrations contributed to the prediction of changes in serum calcitriol (R2 = 0.190, p = 0.012). CONCLUSIONS: Unlike patients with EHR, subjects with HF had low serum 25(OH)D and low free 25(OH)D concentrations at admission, while their serum 1,25D levels were relatively elevated. Decreases in circulating calcitriol levels in the 7 weeks following hip surgery were associated with a resolution of secondary hyperparathyroidism and low availability of free 25(OH)D.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a náhrada kyčelního kloubu $7 D019644
650    _2
$a kalcitriol $x krev $7 D002117
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hojení fraktur $x fyziologie $7 D017102
650    _2
$a fraktury kyčle $x krev $7 D006620
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a osteogeneze $7 D010012
650    _2
$a parathormon $x krev $7 D010281
650    _2
$a prospektivní studie $7 D011446
650    _2
$a referenční hodnoty $7 D012016
650    _2
$a vitamin D $x analogy a deriváty $x krev $7 D014807
655    _2
$a časopisecké články $7 D016428
700    1_
$a Wenchich, L $u Institute of Rheumatology, Prague, Czech Republic
700    1_
$a Bobelyak, M $u Orthopedic Department, Bulovka Hospital, Prague, Czech Republic $u Faculty of Medicine 3, Charles University, Prague, Czech Republic
700    1_
$a Pavelka, K $u Faculty of Medicine 1, Charles University, Prague, Czech Republic $u Institute of Rheumatology, Prague, Czech Republic
700    1_
$a Stepan, J J $u Faculty of Medicine 1, Charles University, Prague, Czech Republic. stepan@revma.cz $u Institute of Rheumatology, Prague, Czech Republic. stepan@revma.cz $1 https://orcid.org/0000000315418306 $7 jn20000402905
773    0_
$w MED00002652 $t Journal of endocrinological investigation $x 1720-8386 $g Roč. 44, č. 9 (2021), s. 1847-1855
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33492601 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130012 $b ABA008
999    __
$a ok $b bmc $g 1789719 $s 1163452
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 44 $c 9 $d 1847-1855 $e 20210125 $i 1720-8386 $m Journal of endocrinological investigation $n J Endocrinol Invest $x MED00002652
GRA    __
$a 00023728 $p Ministerstvo zdravotnictví České Republiky (CZ)
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...